![Kent Rogers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kent Rogers
Keine laufenden Positionen mehr
Profil
Kent Rogers worked as Chief Executive Officer at EveryONE Medicines, Inc. Served as Vice President-Managed Markets at Acorda Therapeutics, Inc. From 2016 to 2021, held the position of Senior Vice President-Industry Relations at OptumRx, Inc. From 2021 to 2023, was Chief Customer Officer at EQRx, Inc. From 2023 to 2026, worked as Venture Partner at ARCH Venture Partners LLC.
Attended Indiana University, completing undergraduate studies in 1991.
Earned an MBA from Goizueta Business School-Emory in 1998.
Ehemalige bekannte Positionen von Kent Rogers
| Unternehmen | Position | Ende |
|---|---|---|
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private Equity Investor | 28.02.2026 |
| EQRX, INC. | Corporate Officer/Principal | 09.11.2023 |
OptumRx, Inc.
 OptumRx, Inc. Investment ManagersFinance Provides pharmacy benefit management services | Investor Relations Kontakt | 01.04.2021 |
EveryONE Medicines, Inc.
 EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Develops precision therapeutics | Vorstandsvorsitzender | - |
| ACORDA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Kent Rogers
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
90
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Acorda Therapeutics, Inc.
 Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
OptumRx, Inc.
OptumRx, Inc. Investment ManagersFinance Provides pharmacy benefit management services | Finance |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goizueta Business School-Emory
 Goizueta Business School-Emory Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EveryONE Medicines, Inc.
EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Develops precision therapeutics | Commercial Services |
EQRx, Inc.
 EQRx, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers medicines for lung cancer | Health Technology |
